Bristol Myers Squibb (NYSE:BMY) today announced that the European Commission (EC) has granted Conditional Marketing Authorization for Abecma (idecabtagene vicleucel; ide-cel), a first-in-class B-cell
Apple Inc (NASDAQ: AAPL) is not giving up on a copyright case it lost against the security firm Corellium that makes computer-based iPhone simulations for researchers, Reuters